CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry

Brief description of study

The purpose of this registry study is to learn more about AA, how doctors treat AA, how well medications and other treatments work, the safety of those treatments, and to improve the care and outcomes of people with AA. Approximately 5,000 men and women ages 18 years and older with a diagnosis of AA in North America are expected to participate in this registry study.

Clinical Study Identifier: s23-00339

Principal Investigator: Kristen Lo Sicco.

Other Investigator: Jerry Shapiro.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies